HEOR Strategy & Evidence Planning
We develop integrated HEOR and evidence generating strategies that identify critical evidence gaps, prioritize research activities, and align clinical, economic, and real-world evidence with payer expectations.
Our senior experts bridge global evidence requirements with local HTA and reimbursement priorities, delivering actionable roadmaps that strengthen value demonstration, optimize evidence investments, and support market access throughout the product lifecycle.
HEOR projects delivered by partners
Minimum years of experience of each team member
What we deliver
Integrated evidence plans
Strategic roadmaps that identify clinical, economic, and RWE gaps, prioritize research activities, and align evidence generation with HTA requirements and commercial priorities.
Payer value proposition
Evidence-based messaging that highlights clinical differentiation, economic benefits, and value while addressing payer concerns to support coverage and reimbursement.
Objection handling
Targeted, evidence-based responses to anticipated payer concerns and objections, strengthening value communication and supporting reimbursement discussions.
Trial design input
Strategic input on clinical and patient-reported outcomes, patient populations, and data collection to strengthen anticipated HTA and reimbursement submissions.
Real-world evidence strategy
Approaches to address evidence gaps, identify appropriate data sources and study designs, and generate robust evidence to support payer decisions.
Literature reviews
Systematic, targeted, or rapid reviews, as appropriate, to synthesize clinical, economic, and real-world evidence.
How we work
- 01
Landscape assessment
Accelerated review of guidelines, HTA precedents, comparator evidence, and payer expectations to understand the reimbursement landscape across target markets.
- 02
Gap analysis
Senior-level assessment of existing clinical, economic, and real-world evidence to identify critical gaps, uncertainties, and market-specific requirements.
- 03
Roadmap
Develop prioritized, actionable evidence plan with recommended studies, analytical approaches, milestones aligned with clinical development and access objectives.
- 04
Execution and ongoing support
Provide targeted or end-to-end support, from study design and evidence generation through economic analyses, HTA submissions, and payer engagement.
Five layers of scientific rigour sit behind every deliverable to strengthen methodological integrity of every deliverable.
- Established precedents
- GRADE approach
- MCID identification
- Internal QC
- Blinded partner review
Why Frontier HEOR
Senior expertise only
Every engagement is delivered directly by senior experts, with no delegation to junior staff.
Scientific rigor at every level
Scientifically rigorous HEOR strategies that critically assess evidence, address uncertainty, and anticipate HTA challenges to strengthen payer confidence and reimbursement
Purposeful scoping
We recommend only work that adds meaningful value, avoiding unnecessary analyses, duplication, and expenditure.